Imbalance between matrix metalloproteinases (MMP-9 and MMP-2) and tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in acute respiratory distress syndrome patients

被引:108
|
作者
Lanchou, J [1 ]
Corbel, M
Tanguy, M
Germain, N
Boichot, E
Theret, N
Clement, B
Lagente, V
Malledant, Y
机构
[1] Univ Rennes, INSERM U456, Rennes, France
[2] CHU Rennes, Hop Pontchaillou, Serv Reanimat Chirurg, Rennes, France
关键词
matrix metalloproteinases; tissue inhibitor of matrix metalloproteinases; acute respiratory distress syndrome; acute lung injury;
D O I
10.1097/01.CCM.0000048626.02184.F8
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: Matrix metalloproteinases (MMPs) are known to be involved in degradation of extracellular matrix. We aimed to assess the role of MMPs and their natural inhibitors (TIMPs) in the genesis and the evolution of acute respiratory distress syndrome (ARDS). Design: Prospective, clinical study. Setting: Intensive care unit of a university hospital. Patients: Twenty-one patients were assigned to three different groups: Group 1 patients developed ARDS that rapidly resolved in <4 days; Group 2 patients developed ARDS lasting >8 days; Group 3 (control group) patients had clinical criteria for hospital-acquired pneumonia without ARDS. Intervention: Bronchoalveolar lavages were performed on day 0 of the onset of ARDS and on days 4, 8, and 12 for unresolving ARDS. For group 3, the bronchoalveolar lavages were performed on day 0 of the pneumonia. On these bronchoalveolar lavage fluids, we measured the amount of MMP-9 and -2 and their inhibitors TIMP-1 and -2. Measurements and Main Results: The amount of MMP-9 measured by enzyme-linked immunosorbent assay was significantly lower in the bronchoalveolar lavages from patients with ARDS (group 1 and group 2) compared with the control group (p < .01) throughout the study. The ratio MMP-9/TIMP-1 was also significantly smaller and was less than one in the two ARDS groups (p < .05) compared with the control group (group 3), where this ratio was greater than one. In the second bronchoalveolar lavages, this ratio was greater than one only in the ARDS group that rapidly resolved (group 1), whereas it stayed less than one when the ARDS was lasting (group 2). Concerning the quantity of MMP-2 and the ratio MMP-2/TIMP-2, there was no statistical difference between the three groups throughout the study. Using zymography, there was no significant difference in the amounts of active and latent MMP-9 between the three groups. Moreover, no significant difference in the quantity of latent and active MMP-2 in the three groups was noted. Conclusion: These results suggest that the MMP-9 level and MMP-9/TIMP-1 ratio play a role in the pathogenesis of ARDS and, namely, the imbalance between MMP-9 and TIMP-1 would participate in airway remodeling leading to either short- or long-course ARDS. The ratio MMP-9/TIMP-1 could be a predictive factor of the ARDS evolution.
引用
收藏
页码:536 / 542
页数:7
相关论文
共 50 条
  • [1] Matrix metalloproteinases (MMP-8, MMP-9) and the tissue inhibitors of metalloproteinases (TIMP-1, TIMP-2) in patients with fungal keratitis
    Rohini, Gomathinayagam
    Murugeswari, Ponnalagu
    Prajna, Namperumalsamy Venkatesh
    Lalitha, Prajna
    Muthukkaruppan, Veerappan
    CORNEA, 2007, 26 (02) : 207 - 211
  • [2] Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer
    Öberg, Å
    Höyhtyä, M
    Tavelin, B
    Stenling, R
    Lindmark, G
    ANTICANCER RESEARCH, 2000, 20 (2B) : 1085 - 1091
  • [3] Elevated serum concentrations of metalloproteinases (MMP-2, MMP-9) and their inhibitors (TIMP-1, TIMP-2) in patients with Graves' orbitopathy
    Kapelko-Slowik, Katarzyna
    Slowik, Miroslaw
    Szalinski, Marek
    Dybko, Jaroslaw
    Wolowiec, Dariusz
    Prajs, Iwona
    Bohdanowicz-Pawlak, Anna
    Biernat, Monika
    Urbaniak-Kujda, Donata
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 27 (01): : 99 - 103
  • [4] Expression of matrix metalloproteinases MMP-2, MMP-9 and their tissue inhibitors TIMP-1 and TIMP-2 in the epithelium and stroma of salivary gland pleomorphic adenomas
    Zhang, Xiaojun
    Wang, Yang
    Yamamoto, Gou
    Tachikawa, Tetsuhiko
    HISTOPATHOLOGY, 2009, 55 (03) : 250 - 260
  • [5] Localization of MMP-2, MMP-9, TIMP-1, and TIMP-2 in human coronal dentine
    Niu, L. N.
    Zhang, L.
    Jiao, K.
    Li, F.
    Ding, Y. X.
    Wang, D. Y.
    Wang, M. Q.
    Tay, F. R.
    Chen, J. H.
    JOURNAL OF DENTISTRY, 2011, 39 (08) : 536 - 542
  • [6] Relationships between MMP-2, MMP-9, TIMP-1 and TIMP-2 levels and their pathogenesis in patients with lupus nephritis
    Jiang, Zhongxin
    Sui, Tao
    Wang, Bin
    RHEUMATOLOGY INTERNATIONAL, 2010, 30 (09) : 1219 - 1226
  • [7] Matrix metalloproteinases (MMP-2 and 9) and tissue inhibitors of matrix metalloproteinases (TIMP-1 and 2) during the course of experimental necrotizing herpetic keratitis
    Yang, YN
    Bauer, D
    Wasmuth, S
    Steuhl, KP
    Heiligenhaus, A
    EXPERIMENTAL EYE RESEARCH, 2003, 77 (02) : 227 - 237
  • [8] MMP-2, MMP-9, TIMP-1, and TIMP-2 in the Peripheral Blood of Patients with Differentiated Thyroid Carcinoma
    Zhang, Wen-jing
    Song, Bing
    Yang, Tao
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 10675 - 10681
  • [9] Evaluation of Matrix Metalloproteinase-2 (MMP-2) and-9 (MMP-9) and Their Tissue Inhibitors (TIMP-1 and TIMP-2) in Plasma from Patients with Neurodegenerative Dementia
    Tuna, Gamze
    Yener, Gorsev Gulmen
    Oktay, Gulgun
    Islekel, Gul Huray
    Kirkali, Fatos Guldal
    JOURNAL OF ALZHEIMERS DISEASE, 2018, 66 (03) : 1265 - 1273
  • [10] Evaluation of MMP-9 and MMP-2 and their suppressor TIMP-1 and TIMP-2 in adenocarcinoma of esophagogastric junction
    Lu, Xiaofei
    Duan, Lingling
    Xie, Hongqin
    Lu, Xiaoxia
    Lu, Daolin
    Lu, Daopeng
    Jiang, Nan
    Chen, Yuxin
    ONCOTARGETS AND THERAPY, 2016, 9 : 4343 - 4349